Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
7.27
+0.68 (10.32%)
Oct 15, 2026, 4:00 PM EDT - Market closed
Capricor Therapeutics Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Capricor Therapeutics stock has a consensus rating of "Buy" and an average price target of $27. The average 1-year stock price forecast is 271.39% higher than the current stock price, while the lowest is $7.00 (-3.71%) and the highest is $54 (+642.78%).
Price Target: $27 (+271.39%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Capricor Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 0 | 2 | 3 | 3 |
| Buy | 2 | 2 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 10 | 7 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Hold Reiterates $7 | Hold | Reiterates | $7 | -3.71% | Oct 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Oct 5, 2026 |
| JonesTrading | JonesTrading | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 28, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Upgrades $5 → $21 | Buy | Upgrades | $5 → $21 | +188.86% | Sep 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Upgrades $2 → $25 | Buy | Upgrades | $2 → $25 | +243.88% | Sep 1, 2026 |
Financial Forecast
Revenue This Year
55.69M
Revenue Next Year
56.54M
from 55.69M
Increased by 1.52%
EPS This Year
-1.45
from -2.26
EPS Next Year
-1.48
from -1.45
EPS and Forward PE are based on non-GAAP adjusted numbers.